2022
DOI: 10.1016/j.bj.2022.03.001
|View full text |Cite
|
Sign up to set email alerts
|

A recipe for a good clinical pulmonary surfactant

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
25
0
2

Year Published

2022
2022
2025
2025

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 30 publications
(27 citation statements)
references
References 140 publications
0
25
0
2
Order By: Relevance
“…For example, PG is generally chosen to mimic the negatively charged lipids found in bacterial membranes (Clausell et al, 2007) and asymmetric lipopolysaccharide-phospholipid bilayers are built to mimic the outer membrane of Gram-negative bacteria (Michel et al, 2017). The extensively studied DPPC represents the paradigmatic lipid to model the lung surfactant (Perez-Gil, 2022). Microphase separated vesicles composed of PC/SM/cholesterol are proposed to mimic raftlike domains with coexisting liquid ordered (l o ) and liquid disordered (l d ) phases (Veatch and Keller, 2003).…”
Section: Discussionmentioning
confidence: 99%
“…For example, PG is generally chosen to mimic the negatively charged lipids found in bacterial membranes (Clausell et al, 2007) and asymmetric lipopolysaccharide-phospholipid bilayers are built to mimic the outer membrane of Gram-negative bacteria (Michel et al, 2017). The extensively studied DPPC represents the paradigmatic lipid to model the lung surfactant (Perez-Gil, 2022). Microphase separated vesicles composed of PC/SM/cholesterol are proposed to mimic raftlike domains with coexisting liquid ordered (l o ) and liquid disordered (l d ) phases (Veatch and Keller, 2003).…”
Section: Discussionmentioning
confidence: 99%
“…PA and higher amounts of DPPC may promote SLS structure in formulations that lack SP-B. ( Perez-Gil, 2022 ).…”
Section: Synthetic Lung Surfactantmentioning
confidence: 99%
“…Some recent work challenges this view, and some formulations choose to include cholesterol, such as the Forbes group of King’s College London (F-KCL in Table 5.1). ( Perez-Gil, 2022 , Hassoun et al, 2018 , Mingarro et al, 2008 ).…”
Section: Synthetic Lung Surfactantmentioning
confidence: 99%
“…Mass production of humanized surfactant protein however poses a major bottleneck in the development of next generation therapeutic surfactants. [ 29 ].…”
Section: Also In This Issuementioning
confidence: 99%